Skip to main content
NCBI home page
Journal of Urban Health : Bulletin of the New York Academy of Medicine logoLink to Journal of Urban Health : Bulletin of the New York Academy of Medicine
. 2004 Jun;81(2):249–259. doi: 10.1093/jurban/jth111

Sexual relationships, secondary syringe exchange, and gender differences in HIV risk among drug injectors

Kara S Riehman 1,✉, Alex H Kral 3, Rachel Anderson 4, Neil Flynn 4, Ricky N Bluthenthal 2
PMCID: PMC3456452  PMID: 15136658

Abstract

Injection drug use continues to place women at risk for human immunodeficiency virus (HIV) through both risky injecting practices and risky sexual behavior with male injection drug users (IDUs). Although attendance at syringe-exchange programs (SEPs) is protective against HIV, a recent study found that women attending SEPs who exchanged syringes for other people (secondary exchange) were at greater risk for HIV seroconversion, potentially through risky sexual behavior. We examined this question in a sample of 531 IDUs (175 women and 356 men) attending 23 SEPs in California in 2001. Findings indicated that women were more likely than men to engage in secondary exchange and were more likely to have IDU sexual partners. In multivariate analysis among women, secondary exchange was independently associated with distributive syringe sharing, not engaging in receptive sharing, and not exchanging sex for money or drugs. Multivariate analysis among men found that having an IDU sexual partner was associated with secondary exchange. Women’s sexual risk behavior was not associated with secondary exchange, and although women’s secondary exchange was associated with individual protection for injection-related behaviors, it may increase network risk. More information on network members is needed to understand gender differences in secondary exchange.

Full Text

The Full Text of this article is available as a PDF (95.9 KB).

Footnotes

Dr. Bluthenthal is with the Health Program and Drug Policy Research Center, RAND. and Drew Center on AIDS Research, Education, and Services (CARES), Department of Psychiatry, Charles R. Drew University of Medicine and Science.

References

  • 1.Centers for Disease Control and Prevention. US HIV and AIDS cases reported through December 2001. HIV AIDS Surveill Rep. 2001;13(2). Available at: www.cdc.gov/hiv/ stats/hasr1302.htm. Accessed January 6, 2003.
  • 2.Centers for Disease Control and Prevention. Drug-associated HIV transmission continues in the United States. 2002. Available at: www.cdc.gov/hiv/pubs/facts/idu.htm. Accessed January 6, 2003.
  • 3.Booth RE. Gender differences in high-risk sex behaviors among heterosexual drug injectors and crack smokers. Am J Drug Alcohol Abuse. 1995;21:419–432. doi: 10.3109/00952999509002708. [DOI] [PubMed] [Google Scholar]
  • 4.Evans JL, Hahn JA, Page-Shafer K, et al. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco. J. Urban Health. 2003;80:137–146. doi: 10.1093/jurban/jtg137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Geoghegan T, O’Shea M, Cox G. Gender differences in characteristics of drug users presenting to a Dublin syringe exchange. Ir J Psychol Med. 1999;16:131–135. [Google Scholar]
  • 6.Riehman K, Iguchi M, Morral A, Zeller M. The influence of partner drug use and relationship power on treatment engagement. Drug Alcohol Depend. 2003;70:1–10. doi: 10.1016/S0376-8716(02)00332-0. [DOI] [PubMed] [Google Scholar]
  • 7.Wechsberg WM, Rounds-Bryant J, Zhang Y. HIV Risk Behaviors by gender and ethnicity among substance abusers entering treatment. J Maintenance Addict. 2003;2:37–63. doi: 10.1300/J126v02n01_04. [DOI] [Google Scholar]
  • 8.Wechsberg WM, Dennis MS, Ying Z. Women and men injectors: differences and trends in their drug use patterns and HIV risk. Paper presented at: meeting of the American Public Health Association; November 1995; San Diego, CA.
  • 9.Wechsberg WM, Cavanaugh ER. Differences found between women in and out of treatment: Implications for interventions. Drugs Soc. 1998;13:65–82. [Google Scholar]
  • 10.Bluthenthal RN, Kral AH, Erringer EA, Edlin BR. Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited injection drug users in Oakland, California, 1992–1995. J Acquir Immune Defic Syndr. 1998;18:505–511. doi: 10.1097/00042560-199808150-00013. [DOI] [PubMed] [Google Scholar]
  • 11.Bluthenthal RN, Kral AH, Gee L, Erringer EA, Edlin BR. The effect of syringe exchange use on high-risk injection drug users: A cohort study. AIDS. 2000;14:605–611. doi: 10.1097/00002030-200003310-00015. [DOI] [PubMed] [Google Scholar]
  • 12.Gibson DR, Brand R, Anderson KT, Kahn JG, Perales D, Guydish J. Two-to sixfold decreased odds of HIV risk behavior associated with use of syringe exchange. J Acquir Immune Defic Syndr. 2002;31:237–242. doi: 10.1097/00126334-200210010-00015. [DOI] [PubMed] [Google Scholar]
  • 13.Hagan H, Thiede H. Changes in injection risk behavior associated with participation in the Seattle needle-exchange program. J Urban Health. 2000;77:369–382. doi: 10.1007/BF02386747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Paone D, Jarlais DC, Shi Q. Syringe exchange use and HIV risk reduction over time [letter] AIDS. 1998;12:121–123. [PubMed] [Google Scholar]
  • 15.Robles RR, Colon HM, Matos TD, et al. Syringe and needle exchange as HIV/AIDS prevention for injection drug users in Puerto Rico. Health Policy. 1998;45:209–220. doi: 10.1016/S0168-8510(98)00046-3. [DOI] [PubMed] [Google Scholar]
  • 16.Vlahov D, Junge B, Brookmeyer R, et al. Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. J Acquir Immune Defic Syndr. 1997;16:400–406. doi: 10.1097/00042560-199712150-00014. [DOI] [PubMed] [Google Scholar]
  • 17.Jarlais DC, Marmor M, Paone D, et al. HIV risk behavior and seroincidence among injection drug users in New York City. Lancet. 1996;348:987–981. doi: 10.1016/S0140-6736(96)02536-6. [DOI] [PubMed] [Google Scholar]
  • 18.Miller M, Eskild A, Mella I, Moi H, Magnus P. Gender differences in syringe exchange program use in Oslo, Norway. Addiction. 2001;96:1639–1651. doi: 10.1046/j.1360-0443.2001.9611163910.x. [DOI] [PubMed] [Google Scholar]
  • 19.Valente TW, Foreman RK, Junge B, Valhov D. Needle-exchange participation, effectiveness, and policy: syringe relay, gender, and the paradox of public health. J Urban Health. 2001;78:340–349. doi: 10.1093/jurban/78.2.340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Schoenbaum EE, Hartel DM, Gourevitch MN. Needle exchange use among a cohort of injecting drug users. AIDS. 1996;10:1729–1734. doi: 10.1097/00002030-199612000-00018. [DOI] [PubMed] [Google Scholar]
  • 21.Des Jarlais DC, McKnight C, Eigo K, Friedmann P. 2000 United States Syringe Exchange Program Survey. North American Syringe Exchange Convention XII; April 24, 2002; Albuquerque, NM.
  • 22.Centers for Disease Control and Prevention Interpretation and use of the Western blot assay for serodiagnosis of HIV type 1 infections. MMWR Morb Mortal Wkly Rep. 1989;37:7–7. [Google Scholar]
  • 23.Archibald CP, Ofner M, Strathdee SA, et al. Factors associated with frequent needle exchange program attendance in injection drug users in Vancouver, Canada. J Acquir Immune Defic Syndr. 1998;17:160–166. doi: 10.1097/00042560-199802010-00010. [DOI] [PubMed] [Google Scholar]
  • 24.Hahn JA, Vranizan KM, Moss AR. Who uses needle exchange? A study of injection drug users in treatment in San Francisco, 1989–1990. J Acquir Immune Defic Syndr. 1997;15:157–164. doi: 10.1097/00042560-199706010-00010. [DOI] [PubMed] [Google Scholar]
  • 25.Fisher DG, Fenaughty AM, Cagle HH, Wells RS. Needle exchange and injection drug use frequency: a randomized clinical trial. J Acquir Immune Defic Syndr. 2003;33:199–205. doi: 10.1097/00126334-200306010-00014. [DOI] [PubMed] [Google Scholar]
  • 26.Watters JK, Estilo MJ, Clark GL, Lorvick J. Syringe and needle exchange as HIV/AIDS prevention for injection drug users. JAMA. 1994;271:115–120. doi: 10.1001/jama.271.2.115. [DOI] [PubMed] [Google Scholar]
  • 27.Huang KHC, Watters JK, Case P. Psychological assessment and AIDS research with intravenous drug users: challenges in measurement. J Psychoactive Drugs. 1988;20:191–195. doi: 10.1080/02791072.1988.10524494. [DOI] [PubMed] [Google Scholar]
  • 28.Dowling-Guyer S, Johnson ME, Fisher DG, et al. Reliability of drug users’ self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment. 1994;1:383–92. [Google Scholar]
  • 29.Watters JK, Needle R, Brown BS, Weatherby N, Booth R, Williams M. The self-reporting of cocaine use [letter] JAMA. 1992;268:2374–2375. doi: 10.1001/jama.268.17.2374. [DOI] [PubMed] [Google Scholar]
  • 30.Weatherby N, Needle R, Cesari H, et al. Validity of self-reported drug use among injection drug users recruited through street outreach. Eval Program Plan. 1994;17:347–355. doi: 10.1016/0149-7189(94)90035-3. [DOI] [Google Scholar]
  • 31.Centers for Disease Control and Prevention Syringe Exchange Program—United States, 1994–1995. Morbidity and Mortality Weekly Report. 1995;44:684–685. [PubMed] [Google Scholar]
  • 32.Centers for Disease Control and Prevention Update: Syringe Exchange Programs—United States, 1998. Morbidity and Mortality Weekly Report. 2001;50(19):384–387. [PubMed] [Google Scholar]
  • 33.Heimer R, Bluthenthal RN, Singer M, Khoshnood K. Structural impediments to operational syringe-exchange programs. AIDS and Public Policy Journal. 1996;11:169–184. [PubMed] [Google Scholar]
  • 34.Bluthenthal RN, Malik R, Grau LE, Singer M, Marshal PA, Heimer R. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities. Addiction. In press. [DOI] [PubMed]
  • 35.Kral AH, Anderson R, Flynn NM, Bluthenthal RN. Injections risk behaviors among clients of syringe exchange programs with different syringe dispensation policies. J AIDS. In press. [DOI] [PubMed]

Articles from Journal of Urban Health : Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine

RESOURCES